title: Growth factors and fibrochondrocytes in scaffolds.
abstract: Four growth factors, transforming growth factor-beta1 (TGF-beta1), platelet-derived growth factor-AB (PDGF-AB), insulin-like growth factor I (IGF-I), and basic fibroblastic growth factor (bFGF), were tested at different concentrations for their effects on extracellular matrix (ECM) production in three-dimensional cultures of meniscal fibrochondrocytes. Cells from New Zealand white rabbits were seeded on poly-glycolic acid (PGA) scaffolds and were stimulated with growth factors for three weeks. (3)H-proline and (35)S-sulfate labels were used to measure uptake of collagen and glycosaminoglycan (GAG) components, respectively. Biochemical assays were performed to measure the total collagen, GAG, and DNA present in the scaffolds at the end of the study. TGF-beta1 (10 and 100 ng/ml) stimulated both (3)H-proline and (35)S-sulfate uptake, showing a dose-dependent response for both and a temporal response for (35)S-sulfate uptake. IGF-I (5 ng/ml) and bFGF (25 and 100 ng/ml) showed increases in (3)H-proline uptake by the third week of growth factor addition. PDGF-AB did not show notable increases in uptake. Because TGF-beta1 (10 and 100 ng/ml) had visibly denser scaffolds, as evidenced by gross microscopy, at 100x, and the strongest uptake responses to both (35)S-sulfate and (3)H-proline, it appears to be the most effective growth factor for use in scaffold-based approaches to tissue engineer the knee meniscus.
authors.affiliation: Department of Bioengineering, Rice University, Houston, Texas 77251, USA. pangborn@rice.edu
authors.forename: Christine A
authors.initials: CA
authors.lastname: Pangborn
authors.forename: Kyriacos A
authors.initials: KA
authors.lastname: Athanasiou
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D019902:Chondrocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D003094:Collagen / Q000096:biosynthesis; D004305:Dose-Response Relationship, Drug; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D006025:Glycosaminoglycans / Q000096:biosynthesis; D006133:Growth Substances / Q000494:pharmacology*; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology; D008592:Menisci, Tibial / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology; D011817:Rabbits; D016212:Transforming Growth Factor beta / Q000494:pharmacology; D053773:Transforming Growth Factor beta1
chemical_list: D006025:Glycosaminoglycans; D006133:Growth Substances; D010982:Platelet-Derived Growth Factor; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; C095477:platelet-derived growth factor AB; D016222:Fibroblast Growth Factor 2; D007334:Insulin-Like Growth Factor I; D003094:Collagen